•  
Polio Vaccination Campaign Begins - India

Polio Vaccination Campaign Begins - India

Polio vaccine vials are seen during a polio vaccination program for children 0-5 Year Old to eradicate polio virus in Srinagar. Srinagar, India, March 3, 2024. Photo by Firdous Nazir/Eyepix Group/ABACAPRESS.COM

  •  
Polio Vaccination Campaign Begins - India

Polio Vaccination Campaign Begins - India

A health worker transports Polio vaccine vials during a polio vaccination program for children 0-5 Year Old to eradicate polio virus in Srinagar. Srinagar, India, March 3, 2024. Photo by Firdous Nazir/Eyepix Group/ABACAPRESS.COM

  •  
Polio Vaccination Campaign Begins - India

Polio Vaccination Campaign Begins - India

A health worker transports Polio vaccine vials during a polio vaccination program for children 0-5 Year Old to eradicate polio virus in Srinagar. Srinagar, India, March 3, 2024. Photo by Firdous Nazir/Eyepix Group/ABACAPRESS.COM

  •  
Polio Vaccination Campaign Begins - India

Polio Vaccination Campaign Begins - India

A health worker checking Polio vaccine vials during a polio vaccination program for children 0-5 Year Old to eradicate polio virus in Srinagar. Srinagar, India, March 3, 2024. Photo by Firdous Nazir/Eyepix Group/ABACAPRESS.COM

  •  
Polio Vaccination Campaign Begins - India

Polio Vaccination Campaign Begins - India

A health worker checking Polio vaccine vials during a polio vaccination program for children 0-5 Year Old to eradicate polio virus in Srinagar. Srinagar, India, March 3, 2024. Photo by Firdous Nazir/Eyepix Group/ABACAPRESS.COM

  •  
Parfums d'Orient Exhibition - Paris

Parfums d'Orient Exhibition - Paris

Perfume vials on display at the Oriental perfumes exhibition. The Arab World Institute invites you to discover oriental perfumes and their history. Along a route of more than 1000 m2 mixing ancient and contemporary works, punctuated with odorous devices and scents specially created by perfumer Christopher Sheldrake, on September 30, 2023 in Paris, France. Photo by Christophe Michel / ABACAPRESS.COM

  •  
Parfums d'Orient Exhibition - Paris

Parfums d'Orient Exhibition - Paris

Perfume vials on display at the Oriental perfumes exhibition. The Arab World Institute invites you to discover oriental perfumes and their history. Along a route of more than 1000 m2 mixing ancient and contemporary works, punctuated with odorous devices and scents specially created by perfumer Christopher Sheldrake, on September 30, 2023 in Paris, France. Photo by Christophe Michel / ABACAPRESS.COM

  •  
Parfums d'Orient Exhibition - Paris

Parfums d'Orient Exhibition - Paris

Perfume vials on display at the Oriental perfumes exhibition. The Arab World Institute invites you to discover oriental perfumes and their history. Along a route of more than 1000 m2 mixing ancient and contemporary works, punctuated with odorous devices and scents specially created by perfumer Christopher Sheldrake, on September 30, 2023 in Paris, France. Photo by Christophe Michel / ABACAPRESS.COM

  •  
Parfums d'Orient Exhibition - Paris

Parfums d'Orient Exhibition - Paris

Perfume vials on display at the Oriental perfumes exhibition. The Arab World Institute invites you to discover oriental perfumes and their history. Along a route of more than 1000 m2 mixing ancient and contemporary works, punctuated with odorous devices and scents specially created by perfumer Christopher Sheldrake, on September 30, 2023 in Paris, France. Photo by Christophe Michel / ABACAPRESS.COM

  •  
Xinhua Headlines: China delivers acclaimed performance in fighting once-in-a-century pandemic

Xinhua Headlines: China delivers acclaimed performance in fighting once-in-a-century pandemic

(230120) -- BEIJING, Jan. 20, 2023 (Xinhua) -- A staff member checks tags on vials of inactivated COVID-19 vaccine at a packing line of Sinovac Life Sciences Co., Ltd. in Beijing, capital of China, on Dec. 23, 2020. (Xinhua/Zhang Yuwei)

  •  
Coronavirus vaccine

Coronavirus vaccine

File photo taken in Tokyo on Oct. 14, 2022, shows vials containing coronavirus vaccine for the Omicron subvariant BA.5.

  •  
Coronavirus vaccine

Coronavirus vaccine

File photo taken in Tokyo on Oct. 14, 2022, shows vials containing coronavirus vaccine for the Omicron subvariant BA.5.

  •  

American expat in China shows how to use COVID-19 antigen self-test kits

STORY: American expat in China shows how to use COVID-19 antigen self-test kits DATELINE: April 2, 2022 LENGTH: 00:04:45 LOCATION: ZHONGSHAN, China CATEGORY: SOCIETY/HEALTH SHOTLIST: 1. SOUNDBITE (English): PAUL BENAVIDES, American expat in China STORYLINE: SOUNDBITE (English): PAUL BENAVIDES, American expat in China "Hi, I'm Paul. The first batch of COVID-19 antigen self-test kits have arrived here in the market in Zhongshan and they are available for purchase for both the citizens and expatriates. I've come to a local drug store to show you how to use these today with the help of the local pharmacist. So we'll grab one box of test kits and of course, some nasal swabs." "This way, please." "OK. Thank you." "Okay. So obviously the first thing we need to do is make sure our hands are clean. So we'll go ahead scrub our hands nice and clean here. Okay, next step is to take one of the vials out of the bag. You can place it on this little hole right here. And then we're going to peel the seal off the vial c

  •  
MYANMAR-YANGON-CHINA-COVID-19-VACCINE-PRODUCTION

MYANMAR-YANGON-CHINA-COVID-19-VACCINE-PRODUCTION

(220323) -- YANGON, March 23, 2022 (Xinhua) -- Staff members pack vials of Myancopharm COVID-19 vaccines at Myanmar Pharmaceutical Industry in Yangon, Myanmar, March 23, 2022. Myanmar launched the production of Myancopharm COVID-19 vaccines here on Wednesday at Myanmar Pharmaceutical Industry in collaboration with China. (Xinhua/U Aung)

  •  
MYANMAR-YANGON-CHINA-COVID-19-VACCINE-PRODUCTION

MYANMAR-YANGON-CHINA-COVID-19-VACCINE-PRODUCTION

(220323) -- YANGON, March 23, 2022 (Xinhua) -- Vials of Myancopharm COVID-19 vaccines are seen on a production line at Myanmar Pharmaceutical Industry in Yangon, Myanmar, March 23, 2022. Myanmar launched the production of Myancopharm COVID-19 vaccines here on Wednesday at Myanmar Pharmaceutical Industry in collaboration with China. (Xinhua/U Aung)

  •  
MYANMAR-YANGON-CHINA-COVID-19-VACCINE-PRODUCTION

MYANMAR-YANGON-CHINA-COVID-19-VACCINE-PRODUCTION

(220323) -- YANGON, March 23, 2022 (Xinhua) -- Vials of Myancopharm COVID-19 vaccine are seen on a production line at Myanmar Pharmaceutical Industry in Yangon, Myanmar, March 23, 2022. Myanmar launched the production of Myancopharm COVID-19 vaccines here on Wednesday at Myanmar Pharmaceutical Industry in collaboration with China. (Xinhua/U Aung)

  •  
EGYPT-GIZA-VACSERA-COVID-19 VACCINE-PRODUCTION

EGYPT-GIZA-VACSERA-COVID-19 VACCINE-PRODUCTION

(220212) -- CAIRO, Feb. 12, 2022 (Xinhua) -- Photo shows vials of COVID-19 vaccine at VACSERA factory in Giza, Egypt, Feb. 3, 2022. TO GO WITH: "Interview: China's grant of fully-automated vaccine cold storage facility "qualitative leap" for Egypt: Egyptian vaccine producer" (Xinhua/Ahmed Gomaa)

  •  
Children Vaccinate Against Covid-19 And Common Diseases - Colombia

Children Vaccinate Against Covid-19 And Common Diseases - Colombia

Empty dose vials of Anti-Flu, Rubella and measles vaccines during a vaccination day inviting mothers and minors over the age of 12 to vaccinate against COVID-19 with the Pfizer BioNtech Coronavirus vaccine and children below the age of 10 to get vaccinated with basic vaccines (Anti-Flu, Rubella and measles) in Bogota, Colombia on August, 28, 2021. Photo by Chepa Beltran/Long Visual Press/ABACAPRESS.COM

  •  
Covid-19 Vaccination - Columbia

Covid-19 Vaccination - Columbia

Vials of Pfizer, AstraZeneca, and CoronaVac vaccines against COVID-19 are applied at the border city of Ipiales located in the department of Narino is one of the cities selected to begin a mass vaccination to achieve an economic reactivation in border area between Colombia and Ecuador in Ipiales, Narino on June 24, 2021 Photo by Camilo Erasso/Long Visual Press/ABACAPRESS.COM

  •  
Covid-19 Vaccination - Columbia

Covid-19 Vaccination - Columbia

Vials of Pfizer, AstraZeneca, and CoronaVac vaccines against COVID-19 are applied at the border city of Ipiales located in the department of Narino is one of the cities selected to begin a mass vaccination to achieve an economic reactivation in border area between Colombia and Ecuador in Ipiales, Narino on June 24, 2021 Photo by Camilo Erasso/Long Visual Press/ABACAPRESS.COM

  •  
Covid-19 Vaccination Center - Nantes

Covid-19 Vaccination Center - Nantes

Storage of Pfizer-BioNTech vaccine vials. Covid-19 vaccination center at the Beaujoire exhibition center in Nantes, France on June 12, 2021. Photo by Ruaud M/ANDBZ/ABACAPRESS.COM

  •  
Pfizer/BioNTech Vaccine Administred At CHU - Lille

Pfizer/BioNTech Vaccine Administred At CHU - Lille

A nurse receives Pfizer/BioNTech vaccine vials against Covid-19 at the CHU hospital Lille, on March 18, 2021, Lille, France. Photo by Julie Sebadelha/ABACAPRESS.COM (Credit:Sebadelha Julie/ABACA/Kyodo News Images)

  •  

Japan halts use of 1.63 mil. Moderna vaccine doses over contamination

Japan's health ministry said Thursday foreign materials were found in some portions of unused doses of Moderna Inc.'s COVID-19 vaccine and the use of around 1.63 million doses manufactured in the same production line has been suspended as a precaution. Japanese drugmaker Takeda Pharmaceutical Co., which is in charge of sales and distribution of the vaccine in the country, said it has yet to see any reports of safety issues. Some of the 1.63 million doses distributed to 863 vaccination centers have already been used. The size of foreign substances confirmed in 39 vials is believed to be a few millimeters, with their elements being unknown. Moderna is conducting an investigation into the materials, according to the ministry and Takeda. The Ministry of Health, Labor and Welfare said foreign substances have been confirmed since Aug. 16 at eight vaccination sites in the prefectures of Ibaraki, Saitama, Tokyo, Gifu and Aichi. Takeda reported them to the ministry on Wednesday.

  •  
COVID-19 vaccination in Japan

COVID-19 vaccination in Japan

Photo shows vials of Pfizer Inc.'s COVID-19 vaccine at a hospital in Iwamizawa, Hokkaido, northern Japan, on Feb. 19, 2021.

  •  
COVID-19 vaccination in Japan

COVID-19 vaccination in Japan

Photo shows vials of Pfizer Inc.'s COVID-19 vaccine at a hospital in Iwamizawa, Hokkaido, northern Japan, on Feb. 19, 2021.

  •  
COVID-19 vaccination in Japan

COVID-19 vaccination in Japan

Photo shows vials of Pfizer Inc.'s COVID-19 vaccine at Kumamoto General Hospital in Yatsushiro, Kumamoto Prefecture, southwestern Japan, on Feb. 19, 2021.

  •  
COVID-19 vaccine developed by Pfizer

COVID-19 vaccine developed by Pfizer

Photo taken Feb. 17, 2021, shows vials of COVID-19 vaccine developed by U.S. drugmaker Pfizer Inc., at a hospital in Ichihara, Chiba Prefecture. Japan began administering COVID-19 vaccinations the same day, with health workers being first to get them.

  •  
COVID-19 vaccine developed by Pfizer

COVID-19 vaccine developed by Pfizer

Photo taken Feb. 17, 2021, shows vials of COVID-19 vaccine developed by U.S. drugmaker Pfizer Inc., at a hospital in Ichihara, Chiba Prefecture. Japan began administering COVID-19 vaccinations the same day, with health workers being first to get them.

  •  
Vaccine developed by Moderna

Vaccine developed by Moderna

Photo shows syringes filled with COVID-19 vaccine developed by Moderna Inc. and empty vials at a large vaccination center set up by the Aichi prefectural government in the town of Toyoyama on May 24, 2021. Inoculations at the center in the central Japan prefecture began the same day.

  •  
Vaccine developed by Moderna

Vaccine developed by Moderna

Photo shows syringes filled with COVID-19 vaccine developed by Moderna Inc. and empty vials at a large vaccination center set up by the Aichi prefectural government in the town of Toyoyama on May 24, 2021. Inoculations at the center in the central Japan prefecture began the same day.

  •  
Vaccine developed by Moderna

Vaccine developed by Moderna

Photo shows syringes filled with COVID-19 vaccine developed by Moderna Inc. and empty vials at a large vaccination center set up by the Aichi prefectural government in the town of Toyoyama on May 24, 2021. Inoculations at the center in the central Japan prefecture began the same day.

  • Main
  • Top
  • Editorial
  • Creative
  • About Us
  • About ILG
  • Terms of use
  • Company
  • BEHIND
  • Price List
  • Single Plan
  • Monthly Plan
  • Services
  • Shooting
  • Rights Clearance
  • Support
  • FAQ
  • How To Buy
  • Contact Us
  • Become a Partner

© KYODO NEWS IMAGES INC

All Rights Reserved.

  • Editorial
  • Olympics
  • News
  • Sports
  • Japan
  • Tech
  • Royal
  • Disaster
  • NorthKorea
  • Old Japan
  • SNS
  • Creative
  • Food
  • Japan
  • Landscape
  • Animal
  • Popular
  • #Ukraine
  • #China
  • #coronavirus
  • #N. Korea
  • #Russia
  • #Thailand
  • #Ukraine
  • #China
  • #coronavirus
  • #N. Korea
  • #Russia
  • #Thailand
  • Food
  • Japan
  • Landscape
  • Animal
  • Olympics
  • News
  • Sports
  • Japan
  • Tech
  • Royal
  • Disaster
  • NorthKorea
  • Old Japan
  • SNS